{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:38:01Z","timestamp":1761561481411},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s12272-010-1007-6","type":"journal-article","created":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T15:39:52Z","timestamp":1288798792000},"page":"1557-1565","source":"Crossref","is-referenced-by-count":37,"title":["How to overcome retinal neuropathy: The fight against angiogenesisrelated blindness"],"prefix":"10.1007","volume":"33","author":[{"given":"Dong Hyun","family":"Jo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Hyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,30]]},"reference":[{"key":"1007_CR1","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1167\/iovs.07-1032","volume":"49","author":"S. F. Abcouwer","year":"2008","unstructured":"Abcouwer, S. F., Shanmugam, S., Gomez, P. F., Shushanov, S., Barber, A. J., Lanoue, K. F., Quinn, P. G., Kester, M., and Gardner, T. W., Effect of IL-1beta on survival and energy metabolism of R28 and RGC-5 retinal neurons. Invest. Ophthalmol. Vis. Sci., 49, 5581\u20135592 (2008).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1007_CR2","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00006982-200412000-00002","volume":"24","author":"D. H. Abramson","year":"2004","unstructured":"Abramson, D. H. and Schefler, A. C., Update on retinoblastoma. Retina, 24, 828\u2013848 (2004).","journal-title":"Retina"},{"key":"1007_CR3","doi-asserted-by":"crossref","first-page":"H628","DOI":"10.1152\/ajpcell.1995.268.3.C628","volume":"268","author":"D. Abran","year":"1995","unstructured":"Abran, D., Varma, D. R., and Chemtob, S., Increased thromboxane-mediated contractions of retinal vessels of newborn pigs to peroxides. Am. J. Physiol., 268, H628\u2013H632 (1995).","journal-title":"Am. J. Physiol."},{"key":"1007_CR4","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"L. P. Aiello","year":"1994","unstructured":"Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., and Park, J. E., Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med., 331, 1480\u20131487 (1994).","journal-title":"N. Engl. J. Med."},{"key":"1007_CR5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1517\/14728210902824141","volume":"14","author":"J. Beutel","year":"2009","unstructured":"Beutel, J., Rudolf, M., and Grisanti, S., Current and future therapies for age-related macular degeneration. Expert Opin. Emerg. Drugs, 14, 341\u2013362 (2009).","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"1007_CR6","first-page":"198","volume":"119","author":"N. M. Bressler","year":"2001","unstructured":"Bressler, N. M., Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch. Ophthalmol., 119, 198\u2013207 (2001).","journal-title":"Arch. Ophthalmol."},{"key":"1007_CR7","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"D. M. Brown","year":"2006","unstructured":"Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., and Schneider, S., Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med., 355, 1432\u20131444 (2006).","journal-title":"N. Engl. J. Med."},{"key":"1007_CR8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","volume":"7","author":"P. Carmeliet","year":"2001","unstructured":"Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., Scholz, D., Acker, T., Dipalma, T., Dewerchin, M., Noel, A., Stalmans, I., Barra, A., Blacher, S., Vandendriessche, T., Ponten, A., Eriksson, U., Plate, K. H., Foidart, J. M., Schaper, W., Charnock-jones, D. S., Hicklin, D. J., Herbert, J. M., Collen, D., and Persico, M. G., Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med., 7, 575\u2013583 (2001).","journal-title":"Nat. Med."},{"key":"1007_CR9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","volume":"10","author":"J. Chen","year":"2007","unstructured":"Chen, J. and Smith, L. E., Retinopathy of prematurity. Angiogenesis, 10, 133\u2013140 (2007).","journal-title":"Angiogenesis"},{"key":"1007_CR10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nm1591","volume":"13","author":"K. M. Connor","year":"2007","unstructured":"Connor, K. M., Sangiovanni, J. P., Lofqvist, C., Aderman, C. M., Chen, J., Higuchi, A., Hong, S., Pravda, E. A., Majchrzak, S., Carper, D., Hellstrom, A., Kang, J. X., Chew, E. Y., Salem, N. Jr., Serhan, C. N., and Smith, L. E., Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med., 13, 868\u2013873 (2007).","journal-title":"Nat. Med."},{"key":"1007_CR11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00146764","volume":"41","author":"J. G. Cunha-Vaz","year":"1976","unstructured":"Cunha-Vaz, J. G., The blood-retinal barriers. Doc. Ophthalmol., 41, 287\u2013327 (1976).","journal-title":"Doc. Ophthalmol."},{"key":"1007_CR12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12020-007-0040-9","volume":"32","author":"J. A. Davidson","year":"2007","unstructured":"Davidson, J. A., Ciulla, T. A., Mcgill, J. B., Kles, K. A., and Anderson, P. W., How the diabetic eye loses vision. Endocrine, 32, 107\u2013116 (2007).","journal-title":"Endocrine"},{"key":"1007_CR13","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMra062326","volume":"355","author":"P. T. Jong De","year":"2006","unstructured":"De Jong, P. T., Age-related macular degeneration. N. Engl. J. Med., 355, 1474\u20131485 (2006).","journal-title":"N. Engl. J. Med."},{"key":"1007_CR14","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1517\/13543780903201684","volume":"18","author":"J. A. Dixon","year":"2009","unstructured":"Dixon, J. A., Oliver, S. C., Olson, J. L., and Mandava, N., VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration. Expert Opin. Investig. Drugs, 18, 1573\u20131580 (2009).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"1007_CR15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jcp.21426","volume":"216","author":"J. Doukas","year":"2008","unstructured":"Doukas, J., Mahesh, S., Umeda, N., Kachi, S., Akiyama, H., Yokoi, K., Cao, J., Chen, Z., Dellamary, L., Tam, B., Racanelli-layton, A., Hood, J., Martin, M., Noronha, G., Soll, R., and Campochiaro, P. A., Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema. J. Cell. Physiol., 216, 29\u201337 (2008).","journal-title":"J. Cell. Physiol."},{"key":"1007_CR16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","volume":"308","author":"A. O. Edwards","year":"2005","unstructured":"Edwards, A. O., Ritter, R. 3rd, Abel, K. J., Manning, A., Panhuysen, C., and Farrer, L. A., Complement factor H polymorphism and age-related macular degeneration. Science, 308, 421\u2013424 (2005).","journal-title":"Science"},{"key":"1007_CR17","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1167\/iovs.02-1022","volume":"44","author":"A. B. El-Remessy","year":"2003","unstructured":"El-Remessy, A. B., Abou-Mohamed, G., Caldwell, R. W., and Caldwell, R. B., High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation. Invest. Ophthalmol. Vis. Sci., 44, 3135\u20133143 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1007_CR18","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archopht.1984.01040031330019","volume":"102","author":"F. L. Ferris 3rd","year":"1984","unstructured":"Ferris, F. L. 3rd, Fine, S. L., and Hyman, L., Age-related macular degeneration and blindness due to neovascular maculopathy. Arch. Ophthalmol., 102, 1640\u20131642 (1984).","journal-title":"Arch. Ophthalmol."},{"key":"1007_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.med.57.121304.131306","volume":"57","author":"J. Folkman","year":"2006","unstructured":"Folkman, J., Angiogenesis. Annu. Rev. Med., 57, 1\u201318 (2006).","journal-title":"Annu. Rev. Med."},{"key":"1007_CR20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra021678","volume":"350","author":"R. N. Frank","year":"2004","unstructured":"Frank, R. N., Diabetic retinopathy. N. Engl. J. Med., 350, 48\u201358 (2004).","journal-title":"N. Engl. J. Med."},{"key":"1007_CR21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.122.7.1019","volume":"122","author":"D. S. Friedman","year":"2004","unstructured":"Friedman, D. S., O\u2019Colmain, B. J., Munoz, B., Tomany, S. C., Mccarty, C., De Jong, P. T., Nemesure, B., Mitchell, P., and Kempen, J., Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol., 122, 564\u2013572 (2004).","journal-title":"Arch. Ophthalmol."},{"key":"1007_CR22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9394(01)01269-7","volume":"133","author":"H. Funatsu","year":"2002","unstructured":"Funatsu, H., Yamashita, H., Noma, H., Mimura, T., Yamashita, T., and Hori, S., Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am. J. Ophthalmol., 133, 70\u201377 (2002).","journal-title":"Am. J. Ophthalmol."},{"key":"1007_CR23","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nature04482","volume":"438","author":"R. F. Gariano","year":"2005","unstructured":"Gariano, R. F. and Gardner, T. W., Retinal angiogenesis in development and disease. Nature, 438, 960\u2013966 (2005).","journal-title":"Nature"},{"key":"1007_CR24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/07853890600946724","volume":"38","author":"K. M. Gehrs","year":"2006","unstructured":"Gehrs, K. M., Anderson, D. H., Johnson, L. V., and Hageman, G. S., Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. Ann. Med., 38, 450\u2013471 (2006).","journal-title":"Ann. Med."},{"key":"1007_CR25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0140-6736(97)01107-0","volume":"350","author":"C. Gilbert","year":"1997","unstructured":"Gilbert, C., Rahi, J., Eckstein, M., O\u2019sullivan, J., and Foster, A., Retinopathy of prematurity in middle-income countries. Lancet, 350, 12\u201314 (1997).","journal-title":"Lancet"},{"key":"1007_CR26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1542\/peds.2004-1413","volume":"116","author":"W. V. Good","year":"2005","unstructured":"Good, W. V., Hardy, R. J., Dobson, V., Palmer, E. A., Phelps, D. L., Quintos, M., and Tung, B., The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics, 116, 15\u201323 (2005).","journal-title":"Pediatrics"},{"key":"1007_CR27","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ophtha.2010.03.032","volume":"117","author":"J. A. Haller","year":"2010","unstructured":"Haller, J. A., Qin, H., Apte, R. S., Beck, R. R., Bressler, N. M., Browning, D. J., Danis, R. P., Glassman, A. R., Googe, J. M., Kollman, C., Lauer, A. K., Peters, M. A., and Stockman, M. E., Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology, 117, 1087\u20131093 e3 (2010).","journal-title":"Ophthalmology"},{"key":"1007_CR28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/08820530902800314","volume":"24","author":"G. Heidary","year":"2009","unstructured":"Heidary, G., Vanderveen, D., and Smith, L. E., Retinopathy of prematurity: current concepts in molecular pathogenesis. Semin. Ophthalmol., 24, 77\u201381 (2009).","journal-title":"Semin. Ophthalmol."},{"key":"1007_CR29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-540-78281-0_7","volume":"180","author":"C. Hellberg","year":"2010","unstructured":"Hellberg, C., Ostman, A., and Heldin, C. H., PDGF and vessel maturation. Recent Results Cancer Res., 180, 103\u2013114 (2010).","journal-title":"Recent Results Cancer Res."},{"key":"1007_CR30","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.101113998","volume":"98","author":"A. Hellstrom","year":"2001","unstructured":"Hellstrom, A., Perruzzi, C., Ju, M., Engstrom, E., Hard, A. L., Liu, J. L., Albertsson-Wikland, K., Carlsson, B., Niklasson, A., Sjodell, L., Leroith, D., Senger, D. R., and Smith, L. E., Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc. Natl. Acad. Sci. U.S.A., 98, 5804\u20135808 (2001).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"1007_CR31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/ICU.0b013e328309f1a5","volume":"19","author":"G. B. Hubbard 3rd","year":"2008","unstructured":"Hubbard, G. B. 3rd, Surgical management of retinopathy of prematurity. Curr. Opin. Ophthalmol., 19, 384\u2013390 (2008).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"1007_CR32","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1056\/NEJMra0801537","volume":"358","author":"R. D. Jager","year":"2008","unstructured":"Jager, R. D., Mieler, W. F., and Miller, J. W., Age-related macular degeneration. N. Engl. J. Med., 358, 2606\u20132617 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1007_CR33","first-page":"1418","volume":"15","author":"A. M. Joussen","year":"2009","unstructured":"Joussen, A. M., Doehmen, S., Le, M. L., Koizumi, K., Radetzky, S., Krohne, T. U., Poulaki, V., Semkova, I., and Kociok, N., TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol. Vis., 15, 1418\u20131428 (2009).","journal-title":"Mol. Vis."},{"key":"1007_CR34","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1096\/fj.03-0329fje","volume":"17","author":"Y. J. Jung","year":"2003","unstructured":"Jung, Y. J., Isaacs, J. S., Lee, S., Trepel, J., and Neckers, L., IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB\/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J., 17, 2115\u20132117 (2003).","journal-title":"FASEB J."},{"key":"1007_CR35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/bjo.2008.144071","volume":"93","author":"P. K. Kaiser","year":"2009","unstructured":"Kaiser, P. K., Vascular endothelial growth factor Trap-Eye for diabetic macular oedema. Br. J. Ophthalmol., 93, 135\u2013136 (2009).","journal-title":"Br. J. Ophthalmol."},{"key":"1007_CR36","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archopht.122.4.552","volume":"122","author":"J. H. Kempen","year":"2004","unstructured":"Kempen, J. H., O\u2019Colmain, B. J., Leske, M. C., Haffner, S. M., KleIn, R., Moss, S. E., Taylor, H. R., and Hamman, R. F., The prevalence of diabetic retinopathy among adults in the United States. Arch. Ophthalmol., 122, 552\u2013563 (2004).","journal-title":"Arch. Ophthalmol."},{"key":"1007_CR37","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3928\/1542-8877-20041101-03","volume":"35","author":"J. H. Kim","year":"2004","unstructured":"Kim, J. H., Khwarg, S. I., Choung, H. K., and Yu, Y. S., Management of porous polyethylene implant exposure in patients with retinoblastoma following enucleation. Ophthalmic Surg. Lasers Imaging, 35, 446\u2013452 (2004).","journal-title":"Ophthalmic Surg. Lasers Imaging"},{"key":"1007_CR38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5483\/BMBRep.2006.39.4.339","volume":"39","author":"J. H. Kim","year":"2006","unstructured":"Kim, J. H., Park, J. A., Lee, S. W., Kim, W. J., Yu, Y. S., and Kim, K. W., Blood-neural barrier: intercellular communication at glio-vascular interface. J. Biochem. Mol. Biol., 39, 339\u2013345 (2006).","journal-title":"J. Biochem. Mol. Biol."},{"key":"1007_CR39","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1111\/j.1582-4934.2008.00243.x","volume":"12","author":"J. H. Kim","year":"2008","unstructured":"Kim, J. H., Yu, Y. S., Shin, J. Y., Lee, H. Y., and Kim, K. W., Deguelin inhibits retinal neovascularization by downregulation of HIF-1alpha in oxygen-induced retinopathy. J. Cell. Mol. Med., 12, 2407\u20132415 (2008).","journal-title":"J. Cell. Mol. Med."},{"key":"1007_CR40","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/jcbfm.2009.78","volume":"29","author":"J. H. Kim","year":"2009","unstructured":"Kim, J. H., Lee, Y. M., Ahn, E. M., Kim, K. W., and Yu, Y. S., Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation. J. Cereb. Blood Flow Metab., 29, 1559\u20131567 (2009a).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"1007_CR41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1021\/mp800178b","volume":"6","author":"J. H. Kim","year":"2009","unstructured":"Kim, J. H., Oh, M., Yu, Y. S., Kim, K. W., and Kwon, H. J., N-hydroxy-7-(2-naphthylthio) heptanomide inhibits retinal and choroidal angiogenesis. Mol. Pharm., 6, 513\u2013519 (2009b).","journal-title":"Mol. Pharm."},{"key":"1007_CR42","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2353\/ajpath.2010.090398","volume":"176","author":"J. H. Kim","year":"2010","unstructured":"Kim, J. H., Jun, H. O., Yu, Y. S., and Kim, K. W., Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy. Am. J. Pathol., 176, 1517\u20131524 (2010).","journal-title":"Am. J. Pathol."},{"key":"1007_CR43","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/86507","volume":"7","author":"M. S. Kim","year":"2001","unstructured":"Kim, M. S., Kwon, H. J., Lee, Y. M., Baek, J. H., Jang, J. E., Lee, S. W., Moon, E. J., Kim, H. S., Lee, S. K., Chung, H. Y., Kim, C. W., and Kim, K. W., Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med., 7, 437\u2013443 (2001).","journal-title":"Nat. Med."},{"key":"1007_CR44","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ajo.2003.11.069","volume":"137","author":"R. Klein","year":"2004","unstructured":"Klein, R., Peto, T., Bird, A., and Vannewkirk, M. R., The epidemiology of age-related macular degeneration. Am. J. Ophthalmol., 137, 486\u2013495 (2004).","journal-title":"Am. J. Ophthalmol."},{"key":"1007_CR45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.81.2.154","volume":"81","author":"M. Kliffen","year":"1997","unstructured":"Kliffen, M., Sharma, H. S., Mooy, C. M., Kerkvliet, S., and De Jong, P. T., Increased expression of angiogenic growth factors in age-related maculopathy. Br. J. Ophthalmol., 81, 154\u2013162 (1997).","journal-title":"Br. J. Ophthalmol."},{"key":"1007_CR46","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1006\/exer.1996.0141","volume":"63","author":"A. Kvanta","year":"1996","unstructured":"Kvanta, A., Steen, B., and Seregard, S., Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma. Exp. Eye Res., 63, 511\u2013518 (1996).","journal-title":"Exp. Eye Res."},{"key":"1007_CR47","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archopht.126.7.953","volume":"126","author":"S. Y. Lee","year":"2008","unstructured":"Lee, S. Y., Kim, D. K., Cho, J. H., Koh, J. Y., and Yoon, Y. H., Inhibitory effect of bevacizumab on the angiogenesis and growth of retinoblastoma. Arch. Ophthalmol., 126, 953\u2013958 (2008).","journal-title":"Arch. Ophthalmol."},{"key":"1007_CR48","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajo.2009.04.004","volume":"148","author":"P. Lin","year":"2009","unstructured":"Lin, P. and O\u2019Brien, J. M., Frontiers in the management of retinoblastoma. Am. J. Ophthalmol., 148, 192\u2013198 (2009).","journal-title":"Am. J. Ophthalmol."},{"key":"1007_CR49","first-page":"855","volume":"37","author":"P. F. Lopez","year":"1996","unstructured":"Lopez, P. F., Sippy, B. D., Lambert, H. M., Thach, A. B., and Hinton, D. R., Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest. Ophthalmol. Vis. Sci., 37, 855\u2013868 (1996).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1007_CR50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/08820530902800322","volume":"24","author":"I. S. Mantagos","year":"2009","unstructured":"Mantagos, I. S., Vanderveen, D. K., and Smith, L. E., Emerging treatments for retinopathy of prematurity. Semin. Ophthalmol., 24, 82\u201386 (2009).","journal-title":"Semin. Ophthalmol."},{"key":"1007_CR51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jaapos.2009.12.002","volume":"14","author":"H. A. Mintz-Hittner","year":"2010","unstructured":"Mintz-Hittner, H. A., Avastin as monotherapy for retinopathy of prematurity. J. AAPOS, 14, 2\u20133 (2010).","journal-title":"J. AAPOS"},{"key":"1007_CR52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000119877","volume":"40","author":"N. Miyamoto","year":"2008","unstructured":"Miyamoto, N., De Kozak, Y., Normand, N., Courtois, Y., Jeanny, J. C., Benezra, D., and Behar-Cohen, F., PlGF-1 and VEGFR-1 pathway regulation of the external epithelial hemato-ocular barrier. A model for retinal edema. Ophthalmic Res., 40, 203\u2013207 (2008).","journal-title":"Ophthalmic Res."},{"key":"1007_CR53","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/11318550-000000000-00000","volume":"24","author":"S. A. Mousa","year":"2010","unstructured":"Mousa, S. A. and Mousa, S. S., Current status of vascular endothelial growth factor inhibition in age-related macular degeneration. BioDrugs, 24, 183\u2013194 (2010).","journal-title":"BioDrugs"},{"key":"1007_CR54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000228926","volume":"223","author":"Z. Ni","year":"2009","unstructured":"Ni, Z. and Hui, P., Emerging pharmacologic therapies for wet age-related macular degeneration. Ophthalmologica, 223, 401\u2013410 (2009).","journal-title":"Ophthalmologica"},{"key":"1007_CR55","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/jnci\/djm007","volume":"99","author":"S. H. Oh","year":"2007","unstructured":"Oh, S. H., Woo, J. K., Yazici, Y. D., Myers, J. N., Kim, W. Y., Jin, Q., Hong, S. S., Park, H. J., Suh, Y. G., Kim, K. W., Hong, W. K., and Lee, H. Y., Structural basis for depletion of heat shock protein 90 client proteins by deguelin. J. Natl. Cancer Inst., 99, 949\u2013961 (2007).","journal-title":"J. Natl. Cancer Inst."},{"key":"1007_CR56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/13543770902762885","volume":"20","author":"A. Ozkiris","year":"2010","unstructured":"Ozkiris, A., Anti-VEGF agents for age-related macular degeneration. Expert Opin. Ther. Pat., 20, 103\u2013118 (2010).","journal-title":"Expert Opin. Ther. Pat."},{"key":"1007_CR57","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0161-6420(91)32074-8","volume":"98","author":"E. A. Palmer","year":"1991","unstructured":"Palmer, E. A., Flynn, J. T., Hardy, R. J., Phelps, D. L., Phillips, C. L., Schaffer, D. B., and Tung, B., Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology, 98, 1628\u20131640 (1991).","journal-title":"Ophthalmology"},{"key":"1007_CR58","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","volume":"27","author":"J. S. Penn","year":"2008","unstructured":"Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., and Hartnett, M. E., Vascular endothelial growth factor in eye disease. Prog. Retin. Eye Res., 27, 331\u2013371 (2008).","journal-title":"Prog. Retin. Eye Res."},{"key":"1007_CR59","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1167\/iovs.08-2654","volume":"50","author":"Y. PIna","year":"2009","unstructured":"PIna, Y., Boutrid, H., Schefler, A., Dubovy, S., Feuer, W., Jockovich, M. E., and Murray, T. G., Blood vessel maturation in retinoblastoma tumors: spatial distribution of neovessels and mature vessels and its impact on ocular treatment. Invest. Ophthalmol. Vis. Sci., 50, 1020\u20131024 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1007_CR60","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm0603-677","volume":"9","author":"C. W. Pugh","year":"2003","unstructured":"Pugh, C. W. and Ratcliffe, P. J., Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med., 9, 677\u2013684 (2003).","journal-title":"Nat. Med."},{"key":"1007_CR61","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/ICU.0b013e3281107fd3","volume":"18","author":"P. A. Quiram","year":"2007","unstructured":"Quiram, P. A. and Capone, A. Jr., Current understanding and management of retinopathy of prematurity. Curr. Opin. Ophthalmol., 18, 228\u2013234 (2007).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"1007_CR62","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/archopht.124.1.24","volume":"124","author":"M. X. Repka","year":"2006","unstructured":"Repka, M. X., Tung, B., Good, W. V., Shapiro, M., Capone, A., Jr., Baker, J. D., Barr, C. C., Phelps, D. L., and Van Heuven, W. A., Outcome of eyes developing retinal detachment during the early treatment for retinopathy of prematurity study (ETROP). Arch. Ophthalmol., 124, 24\u201330 (2006).","journal-title":"Arch. Ophthalmol."},{"key":"1007_CR63","doi-asserted-by":"crossref","first-page":"7924","DOI":"10.1158\/1078-0432.CCR-08-0378","volume":"14","author":"A. D. Ricart","year":"2008","unstructured":"Ricart, A. D., Tolcher, A. W., Liu, G., Holen, K., Schwartz, G., Albertini, M., Weiss, G., Yazji, S., Ng, C., and Wilding, G., Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study. Clin. Cancer Res., 14, 7924\u20137929 (2008).","journal-title":"Clin. Cancer Res."},{"key":"1007_CR64","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/IAE.0b013e31818a1ee7","volume":"29","author":"E. Rishi","year":"2009","unstructured":"Rishi, E., Rishi, P., Ratra, D., and Bhende, M., Off-label use of bevacizumab in retinopathy of prematurity. Retina, 29, 284; author reply 284\u2013285 (2009).","journal-title":"Retina"},{"key":"1007_CR65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.biocel.2009.10.006","volume":"42","author":"P. Sapieha","year":"2010","unstructured":"Sapieha, P., Hamel, D., Shao, Z., Rivera, J. C., Zaniolo, K., Joyal, J. S., and Chemtob, S., Proliferative retinopathies: angiogenesis that blinds. Int. J. Biochem. Cell Biol., 42, 5\u201312 (2010).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"1007_CR66","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.ophtha.2009.04.026","volume":"116","author":"T. Sato","year":"2009","unstructured":"Sato, T., Kusaka, S., Shimojo, H., and Fujikado, T., Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity. Ophthalmology, 116, 2165\u20132169 (2009).","journal-title":"Ophthalmology"},{"key":"1007_CR67","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrm1366","volume":"5","author":"C. J. Schofield","year":"2004","unstructured":"Schofield, C. J. and Ratcliffe, P. J., Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol., 5, 343\u2013354 (2004).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1007_CR68","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2337\/diacare.28.2.445","volume":"28","author":"P. P. Sfikakis","year":"2005","unstructured":"Sfikakis, P. P., Markomichelakis, N., Theodossiadis, G. P., Grigoropoulos, V., Katsilambros, N., and Theodossiadis, P. G., Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab. Diabetes Care, 28, 445\u2013447 (2005).","journal-title":"Diabetes Care"},{"key":"1007_CR69","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.gt.3302641","volume":"13","author":"J. Shen","year":"2006","unstructured":"Shen, J., Samul, R., Silva, R. L., Akiyama, H., Liu, H., Saishin, Y., Hackett, S. F., Zinnen, S., Kossen, K., Fosnaugh, K., Vargeese, C., Gomez, A., Bouhana, K., Aitchison, R., Pavco, P., and Campochiaro, P. A., Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther., 13, 225\u2013234 (2006).","journal-title":"Gene Ther."},{"key":"1007_CR70","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/bjo.77.9.544","volume":"77","author":"C. L. Shields","year":"1993","unstructured":"Shields, C. L., Shields, J. A., Baez, K. A., Cater, J., and De Potter, P. V., Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br. J. Ophthalmol., 77, 544\u2013548 (1993).","journal-title":"Br. J. Ophthalmol."},{"key":"1007_CR71","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1097-0142(19940201)73:3<692::AID-CNCR2820730331>3.0.CO;2-8","volume":"73","author":"C. L. Shields","year":"1994","unstructured":"Shields, C. L., Shields, J. A., Baez, K., Cater, J. R., and De Potter, P., Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer, 73, 692\u2013698 (1994).","journal-title":"Cancer"},{"key":"1007_CR72","doi-asserted-by":"crossref","unstructured":"Singerman, L., Combination therapy using the small interfering RNA bevasiranib. Retina, 29, S49-S50 (2009).","DOI":"10.1097\/IAE.0b013e3181ad2341"},{"key":"1007_CR73","first-page":"373","volume":"19","author":"J. S. Slakter","year":"2006","unstructured":"Slakter, J. S., Anecortave acetate for treating or preventing choroidal neovascularization. Ophthalmol. Clin. North Am., 19, 373\u2013380 (2006).","journal-title":"Ophthalmol. Clin. North Am."},{"key":"1007_CR74","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0039-6257(99)00036-3","volume":"43","author":"W. E. Smiddy","year":"1999","unstructured":"Smiddy, W. E. and Flynn, H. W. Jr., Vitrectomy in the management of diabetic retinopathy. Surv. Ophthalmol., 43, 491\u2013507 (1999).","journal-title":"Surv. Ophthalmol."},{"key":"1007_CR75","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/(SICI)1096-9896(1998110)186:3<306::AID-PATH183>3.0.CO;2-B","volume":"186","author":"A. W. Stitt","year":"1998","unstructured":"Stitt, A. W., Simpson, D. A., Boocock, C., Gardiner, T. A., Murphy, G. M., and Archer, D. B., Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours. J. Pathol., 186, 306\u2013312 (1998).","journal-title":"J. Pathol."},{"key":"1007_CR76","doi-asserted-by":"crossref","first-page":"16939","DOI":"10.1074\/jbc.M808166200","volume":"284","author":"J. M. Thurman","year":"2009","unstructured":"Thurman, J. M., Renner, B., Kunchithapautham, K., Ferreira, V. P., Pangburn, M. K., Ablonczy, Z., Tomlinson, S., Holers, V. M., and Rohrer, B., Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury. J. Biol. Chem., 284, 16939\u201316947 (2009).","journal-title":"J. Biol. Chem."},{"key":"1007_CR77","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1016\/j.visres.2004.07.041","volume":"44","author":"N. Tian","year":"2004","unstructured":"Tian, N., Visual experience and maturation of retinal synaptic pathways. Vision Res., 44, 3307\u20133316 (2004).","journal-title":"Vision Res."},{"key":"1007_CR78","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/156652409789712783","volume":"9","author":"M. J. Tolentino","year":"2009","unstructured":"Tolentino, M. J., Current molecular understanding and future treatment strategies for pathologic ocular neovascularization. Curr. Mol. Med., 9, 973\u2013981 (2009).","journal-title":"Curr. Mol. Med."},{"key":"1007_CR79","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature03987","volume":"437","author":"S. M. Weis","year":"2005","unstructured":"Weis, S. M. and Cheresh, D. A., Pathophysiological consequences of VEGF-induced vascular permeability. Nature, 437, 497\u2013504 (2005).","journal-title":"Nature"},{"key":"1007_CR80","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archophthalmol.2009.265","volume":"127","author":"G. Zahn","year":"2009","unstructured":"Zahn, G., Vossmeyer, D., Stragies, R., Wills, M., Wong, C. G., Loffler, K. U., Adamis, A. P., and Knolle, J., Preclinical evaluation of the novel small-molecule integrin alpha5beta1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization. Arch. Ophthalmol., 127, 1329\u20131335 (2009).","journal-title":"Arch. Ophthalmol."}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-010-1007-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-010-1007-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-010-1007-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T16:22:49Z","timestamp":1559578969000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-010-1007-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":80,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["1007"],"URL":"https:\/\/doi.org\/10.1007\/s12272-010-1007-6","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}